600535.SHG Tasly Pharmaceutical Group Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
14.33 CNY
Close of Nov 4, 2026
12.90 16.24
Market cap
CNY 21.4B
P/E
17.7x
P/B
1.67x
ROE
11.4%
Dividend yield
2.86%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600535.SHG undervalued?

Graham number
Price14.33
Graham value12.51
Premium14.5%

600535.SHG trades 14.5% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tasly Pharmaceutical Group Co Ltd fundamental analysis

No fundamental analysis for Tasly Pharmaceutical Group Co Ltd yet.

Tasly Pharmaceutical Group Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tasly Pharmaceutical Group Co Ltd

Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore…

Full company profile